Resources

For the latest in discovery & development, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Pharma Data

The Evolution of Pharma Data Practices

Pharma data practices have evolved with the times. Today, approaches such as AI and machine learning afford the opportunity to enhance drug development and safety, culminating in AI-driven insights that promise better patient outcomes.
Pharma Data

Array Insights Launches a Data Federation Platform to Help Advance Collaborative Health Research

Pharma data company Array Insights has launched a cutting-edge data federation platform to enable patient-focused organisations to securely access and share patient data for collaborative healthcare research while prioritising patient privacy.
Organ Modelling

Experts Discuss Next Generation Organoids: Challenges and the Future

How do scientists secure the tissue they need? Should scientists be careful with the words they use for next generation technologies? And why is validation for organ modelling so important?
Pharma Data

FAIR Metadata: Management and Principles

Metadata is a crucial aspect of implementing FAIR data principles and practices. Without metadata, you have no view of what is going on with your unstructured data, context as to what the data is or what it is for.
Organ Modelling

Changing How We Look at Tumours

Building 3D cell culture models for predictive in vivo and translational results
Automation

End-To-End Automation: A Journey Towards Heightened Laboratory Efficiency

In this Commentary article, we explore the applications of end-to-end automation in accelerating workflows through the use of robotics and informatics.
Target Discovery

Navigating DEL Screening from Hit to Lead

The panel at Drug Discovery US discussed hit finding technologies, protein availability for screening, and hit-to-lead transition.

Challenges in Developing Organoids for Neuroscience

Oxford Global’s panel discussion: Translational Models from 3D to Animal Model of Disease – Neuroscience, asked experts to share their experience of developing organoids for translational neuroscience.
Organ Modelling

Cultrex™ Extracellular Matrix And Proteins

CultrexTM Basement Membrane Extract (BME)

Prothena and Evotec Score Major Deals with Bristol Myers Squibb for Neuroscience Breakthroughs

Prothena will receive $55 million to license its clinical Alzheimer's drug candidate, while Evotec will receive $40 million for its late-stage clinical programs.
Pharma Data

A Guide to Successful Real World Evidence Implementation

How can you overcome challenges and unleash the potential of Real-World Evidence for impactful healthcare insights?

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery